4//SEC Filing
Trost Timothy W. 4
Accession 0000899243-21-018113
CIK 0001785530other
Filed
May 3, 8:00 PM ET
Accepted
May 4, 4:31 PM ET
Size
8.0 KB
Accession
0000899243-21-018113
Insider Transaction Report
Form 4
Trost Timothy W.
Chief Financial Officer
Transactions
- Award
Stock Option (right to buy)
2021-02-12+247,812→ 247,812 totalExercise: $5.98Exp: 2031-02-11→ Common Stock (247,812 underlying) - Award
Stock Option (right to buy)
2021-04-30+54,756→ 54,756 totalExercise: $16.00Exp: 2031-04-29→ Common Stock (54,756 underlying)
Footnotes (2)
- [F1]The option was granted on February 12, 2021 with a Vesting Commencement Date of February 8, 2021. The shares underlying the option vest over four years, with 25% of the shares vesting on the first anniversary of the Vesting Commencement Date and 2.0833% of the shares vesting each month thereafter through February 8, 2025.
- [F2]The option was granted on April 30, 2021. The shares underlying the option vest over four years in equal monthly installments through April 30, 2025.
Documents
Issuer
Werewolf Therapeutics, Inc.
CIK 0001785530
Entity typeother
Related Parties
1- filerCIK 0001571865
Filing Metadata
- Form type
- 4
- Filed
- May 3, 8:00 PM ET
- Accepted
- May 4, 4:31 PM ET
- Size
- 8.0 KB